Portal de investigación
- Inicio
- Proyectos y Estudios
- ESTUDIO RANDOMIZADO, DOBLE CIEGO, CON GRUPOS DE TRATAMIENTO PARALELOS, PARA EVALUAR LA SEGURIDAD Y EL EFECTO SOBRE EL RESULTADO CLINICO DE TOCILIZUMAB SC FRENTE A TOCILIZUMAB IV EN COMBINACION CON FARMACOS ANTIRREUMATICOS MODIFICADORES DE LA ENFERMEDAD (F AMES) TRADICIONALES, EN PACIENTES CON ARTRITIS REUMATOIDE ACTIVA MODERADA A SEVERA.
ESTUDIO RANDOMIZADO, DOBLE CIEGO, CON GRUPOS DE TRATAMIENTO PARALELOS, PARA EVALUAR LA SEGURIDAD Y EL EFECTO SOBRE EL RESULTADO CLINICO DE TOCILIZUMAB SC FRENTE A TOCILIZUMAB IV EN COMBINACION CON FARMACOS ANTIRREUMATICOS MODIFICADORES DE LA ENFERMEDAD (F AMES) TRADICIONALES, EN PACIENTES CON ARTRITIS REUMATOIDE ACTIVA MODERADA A SEVERA.
Datos básicos
- Código:
- WA22762
- Protocolo:
- WA22762
- EUDRACT:
- 2010-018375-22
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry
Estrada-Alarcon, Paula V.; (...); Blanco, Ricardo
Meeting Abstract. 2023
ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
De Miguel, Eugenio; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
After JAK Inhibitor Failure, "Switching" or "Cycling"?
Munoz Martinez, Pablo Francisco; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
AFTER JAK INHIBITOR FAILURE, 'SWITCHING' OR 'CYCLING'?
Munoz Martinez, P.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4124. 2023
ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3114. 2021
ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Barcena, C. Riesco; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2847. 2022
Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis
Martinez Calabuig, Pablo; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Autologous stem cell transplantation in systemic sclerosis: 4 cases.
de la Rubia Navarro, Marta, Leal Rodriguez, Samuel, Roman Ivorra, Jose Andres
Article. 10.1016/j.reumae.2025.501810. 2025
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT
Altabas Gonzalez, I.; (...); Rua-Figueroa, I.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3003. 2023
Cardiovascular risk assessment with carotid ultrasound in rheumatoid arthritis.
González Mazarío R; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2022.01.017. 2022
CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2
Navarro, M. De la Rubia; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4559. 2022
CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)
Torrat Noves, A. M.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023
COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)
Rua-Figueroa, I.; (...); Pego-Reigosa, J. M.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4168. 2023
CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3157. 2021
COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL
Munoz Martinez, P.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4263. 2023
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.
de la Rubia Navarro, Marta; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.05.003. 2022
Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.
Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.03.026. 2023
EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT
Altabas Gonzalez, I.; (...); Rua-Figueroa, I.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3482. 2023
Effectiveness of Tocilizumab in Cranial and Extracranial Phenotypes of Giant Cell Arteritis: Multicenter Study of 471 Cases
Sanchez-Bilbao, Lara; (...); Blanco, Ricardo
Meeting Abstract. 2021
Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice
Sanchez-Bilbao, Lara; (...); Blanco, Ricardo
Meeting Abstract. 2021
EPIDEMIOLOGY, DIAGNOSIS AND CLINICAL CHARACTERISTICS OF GIANT CELL ARTERITIS IN PATIENTS INCLUDED IN THE ARTESER MULTICENTER STUDY
Sanchez-Costa, J. T.; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.1313. 2022
EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OFTHEVACCINE AGAINST HERPES ZOSTER
Mas Sanchez, L.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4258. 2023
Giant Cell Arteritis Subtypes: Data from the ARTESER Registry
De Miguel, Eugenio; (...); Blanco, Ricardo
Meeting Abstract. 2021
Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome
Munoz Martinez, Pablo; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
HEALTH-RELATED QUALITY OF LIFE MEASURES IN SPONDYLOARTHROPATY PATIENTS UNDER BIOLOGICAL THERAPIES IN REAL LIFE
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.2282. 2021
Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab.
Riesco-Bárcena C; (...); Román-Ivorra J
Article. 10.1016/j.medcli.2024.07.020. 2024
IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT
Garcia, E. Grau; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3917. 2022
Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study
Sanchez-Costa, Jesus T.; (...); Blanco, Ricardo
Meeting Abstract. 2021
Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
Riesco Barcena, Carmen; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients
Grau Garcia, Elena; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
De Miguel, Eugenio; (...); Blanco, Ricardo
Article. 10.1136/rmdopen-2022-002507. 2022
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022)
De Miguel, Eugenio; (...); Blanco, Ricardo
Correction. 10.1136/rmdopen-2022-002507corr1. 2023
Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments
Altabas Gonzalez, Irene; (...); Rua-Figueroa, Inigo
Meeting Abstract. 2023
JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.
Leal S; (...); Román-Ivorra JA
Letter. 10.55563/clinexprheumatol/4ao14k. 2024
LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT
De la Rubia Navarro, M.; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2944. 2022
Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry
Molina-Collada, Juan; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry
Molina-Collada, Juan; (...); ARTESER Project Collaborative Grp, Clara
Article. 10.1186/s13075-024-03468-6. 2025
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Rua-Figueroa, Inigo; (...); Calvo Alen, Jaime
Article. 10.1016/j.reuma.2024.03.005. 2024
Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome
Mas Sanchez, Laura; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.
Zafra J; (...); Barragán I
Article. 10.3390/ijms25084533. 2024
Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning
Román Ivorra JA; (...); Castellanos-Moreira R
Article. 10.1136/rmdopen-2023-003353. 2024
PREVALENCE AND COMORBIDITIES OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN SPAIN: A RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORDS USING NATURAL LANGUAGE PROCESSING
Roman Ivorra, J. A.; (...); Lujan Valdes, S.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.5042. 2022
PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.
Perales, C. Pavez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4143. 2022
PROFILE OF REAL WORLD AXIAL SPONDYLOARTHRITIS PATIENTS REFRACTORY TO ADVANCED THERAPY
Alcantara Alvarez, I; (...); Roman Ivorra, J. A.
Meeting Abstract. 2024
PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE
Garcia, E. Grau; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4014. 2023
PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS
Cordellat, I. Martinez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3898. 2022
PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.
Ortiz-Sanjuan, F.; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3085. 2022
REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65
Grau Garcia, E.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3018. 2023
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study
Gonzalez Mazario, Roxana; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2021.08.001. 2022
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study.
González Mazarío R; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2021.08.004. 2022
Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain
Roman Ivorra, Jose A., Llevat, Noelia, Montoro, Maria
Article. 10.5582/ddt.2022.01028. 2022
Refractory RA Patients for Targeted Therapies in Real Life
Grau Garcia, Elena; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype
Hurtado, Andres Perez; (...); Ivorraa, Jose Andres Roman
Article. 10.1016/j.medcli.2024.09.006. 2025
SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound
Campos Fernandez, Cristina; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME
Oller Rodriguez, J. E.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3312. 2022
Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta
Ramos Castro, Daniel; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Grau García E; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2022.11.019. 2023
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.
Altabás-González I; (...); Rúa-Figueroa I
Article. 10.1093/rheumatology/kead696. 2024
TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL.
Perales, C. Pavez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4126. 2022
USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES
Ortiz Sanjuan, F.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.2961. 2023
Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis.
Oller-Rodriguez, Jose E.; (...); Roman Ivorra, Jose A.
Article. 10.1016/j.medcli.2021.12.006. 2022
Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry
Molina-Collada, Juan; (...); Blanco, Ricardo
Meeting Abstract. 2023